The aim of this study is to compare the success rate of outpatient surgery after holmium LASER enucleation of the prostate (HoLEP) for the treatment of BPH with and without the use of the MOSES 2.0 effect.
HoLEP is in the process of becoming the new reference surgical treatment for BPH with the main advantages over monopolar transurethral resection (TURPm) and high approach adenomectomy (AVH): the significant reduction in morbidity perioperative period and therefore the reduction in the length of hospital stay. This reduction in length of stay has led to the development of outpatient care with encouraging results. The main cause of discharge failure on D0 is the persistence of postoperative hematuria requiring maintenance of bladder irrigation. MOSESTM 2.0 technology has the advantage of better hemostasis compared to the LASER LP100 currently used. The objective of this study is to evaluate the influence of MOSESTM 2.0 technology on the outpatient success rate in patients operated on for HoLEP for BPH.
Study Type
OBSERVATIONAL
Enrollment
200
HoLEP surgery for the treatment of Benign Prostate Hyperthrophy, without using MOSES technology
HoLEP surgery for the treatment of Benign Prostate Hyperthrophy, with the use of MOSES technology
CHU de Bordeaux
Bordeaux, France
Number of patient who discharge on D0 (same day of his surgery)
Time frame: baseline
Number of hour's hospitalization
Time frame: baseline
Number of hour's surgery time
Time frame: baseline
Rate of enucleated prostate tissue By time treatment per patient
Time frame: baseline
number of minutes use of the LASER during surgery
Time frame: baseline
quantity of energy used during the intervention per patient
Time frame: baseline
Intraoperative transfusion rate
Time frame: baseline
Duration of post-operative sounding (hours)
Time frame: baseline
Readmission rate within 48 hours of discharge from hospital
Time frame: baseline
Mean change in IPSS before surgery and 3 months after surgery
Time frame: 3 months after surgery
Mean change in QoL before surgery and 3 months after surgery
Time frame: 3 months after surgery
Mean change in IIEF-5 before surgery and 3 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 months after surgery
Mean change in ICIQ-short form score before surgery and 3 months after surgery
Time frame: 3 months after surgery
Mean change in USP before surgery and 3 months after surgery
Time frame: 3 months after surgery
Mean evolution of Qmax and post-void residual (RPM) before the intervention and at 3 months post-operative
Time frame: 3 months after surgery